XEOMIN® in Armonk, New York

Xeomin is composed of botulinum toxin (type A), a naturally occurring protein that is produced by the bacteria Clostridium botulinum. Xeomin is injected into the affected muscles in order to reduce their activity. Xeomin does not stop the muscle from moving entirely; instead, it modifies the contractions. This is achieved by inhibiting a body chemical called acetylcholine from signaling all of the nerves within the muscle to contract. Dr. Gordon is one of 3% of doctors qualified as an ExpertInjector™ by the American Society for Aesthetic Plastic Surgery (ASAPS) and the American Society for Dermatologic Surgery (ASDS). Dr. Gordon has a special expertise in refined injection techniques that reveal a younger & natural appearance.

During the initial consultation, Dr. Gordon will examine the patient’s areas of concern and discuss treatment options. Xeomin is often used to treat the glabellar lines (the creases between the eyebrows) and moderate to severe frown lines. Dr. Gordon, an Expert Injector, usually takes 15 minutes to complete a Xeomin treatment in his on-site minor procedures room. 

Patients are able to leave right after their treatment with no activity restrictions. A follow up appointment will be scheduled for 1 – 2 weeks after the procedure so Dr. Gordon can monitor the patient’s progress and any reactions. The number of injections necessary will vary from patient to patient, depending upon the number of muscles affected and the severity of the condition. The results of treatment with Xeomin are usually seen after one week and last, on the average, up to 12 weeks.

Patients should expect to pay between $500 and $1,000 for one treatment of Xeomin. The cost is based on the amount of Xeomin used during the procedure.

Xeomin: What You Should Know

In addition to its cosmetic uses, Xeomin can be used to effectively treat intramuscular conditions such as blepharospasm, or abnormal involuntary closing of the eyelid. Blepharospasm is a condition involving abnormal involuntary spasms of the eyelids. Injections of Xeomin administered into the muscles of the eyelid can help relieve spasms for many patients. 

Xeomin ensures that their product is safe with a state of the art manufacturing process that purifies the botulinum toxin (type A). The process removes unnecessary components and results in a highly purified neurotoxin.

Xeomin has been approved by the U.S. Food & Drug Administration (FDA) since 2010 for cosmetic and medical uses. Xeomin has been widely used in other countries since 2005. Patients should inform Dr. Gordon of their medical history before treatment to avoid any complications. Patients should report any side effects to Dr. Gordon.